Prevalence of gastroesophageal reflux disease in patients with rheumatoid arthritis

Ismail, Mohamed Ali; Ibrahim, Doaa; Mustafa, Dalia; Meghezel, El-Zahraa Mohammed

doi:10.21608/smj.2017.41242

Prevalence of gastroesophageal reflux disease in patients with rheumatoid arthritis

Document Type : Original Article

Authors

¹ Rheumatology & rehabilitation department, faculty of medicine, Sohag University, Sohag, Egypt

² Department of Rheumatology and Rehabilitation, Sohag Faculty of Medicine, Sohag University

³ Department of Tropical medicine and Gastroenterology, Sohag Faculty of Medicine, Sohag University

10.21608/smj.2017.41242

Abstract

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune systemic inflammatory multisystem disease of unknown cause marked by symmetric, peripheral polyarthritis The prevalence of GERD began to increase from the end of the 1990s, and is now very common, especially in the elderly population, ranging from 1.4% to 52.1% in the literature, Furthermore, GERD often accompanies many chronic diseases such as diabetic mellitus (DM), chronic liver disease, obstructive sleep apnea syndrome (OSAS), and bronchial asthma.
Aim of the work: To assess the prevalence of GERD symptoms in patients with Rheumatoid arthritis (RA).
Patients and Methods: Case control study, included 100 adult rheumatoid arthritis patients and 25 age and sex matching control patients recruited from rheumatology out patient clinics in Sohag university hospital diagnosed according to the European League Against Rheumatism (EULAR) classification criteria 2010 for RA.
Results: Rheumatoid arthritis can be considered as an independent risk factor for GERD. Disease activity could not be considered as risk factor for GERD
Conclusion: Our results showed that in the present group of RA patients mean of GERD questionnaire was 10.4 which is higher in case group than control group with significant difference

Keywords

RA
GERD

References

1. Nampei A, Shi K, Ebina K, Tomita T, Sugamoto K, Yoshikawa H, et al. Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritis. Journal of clinical biochem-istry and nutrition. 2013;52(2):179-84.

2. Ates F, Yuksel ES, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, et al. Mucosal impedance discriminates GERD from non-GERD conditions. Gastroenterology. 2015;148(2):334-43.

3. Miura Y, Fukuda K, Maeda T, Kurosaka M. Gastroesophageal reflux disease in patients with rheumatoid arthritis. Modern rheumatology. 2014;24(2):291-5.

4. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Annals of the rheumatic diseases. 2007;66(11):1491-6.

5. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis and rheumatism. 1992;35(2):152-5.

6. Kuroda T, Tanabe N, Kobayashi D, Sato H, Wada Y, Murakami S, et al. Association bet-ween clinical parameters and amyloid-positive area in gastroduodenal biopsy in reactive amyloidosis associated with rheumatoid arthritis. Rheumatology international. 2012;32(4):933-9.

7. Dhir V, Lawrence A, Aggarwal A, Misra R. Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. The Journal of rheumatology. 2009;36(11):2443-8.

8. Deo SS, Chogle AR, Mistry KJ, Shetty RR, Nadkar UL. Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. Experimental and clinical cardiology. 2012;17(1):20-5.

9. Miyakoshi N, Kasukawa Y, Sasaki H, Kamo K, Shimada Y. Impact of spinal kyphosis on gastroesophageal reflux disease symptoms in patients with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2009, 207):1193-8

10. Cryer B, Luo X, Assaf AR, Sands G, Mardekian J. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis. Current medical research and opinion. 2011;27(2):295-302.